Erlong Zuoci Wan
Natural health product licensed in Canada
- Licence holder
- T.C. Unicorn Ltd.
- NPN or DIN-HM
- 80008736
- Status
- Active licence
- Licence date
- 21 February 2009
- Revision date
- 23 March 2009
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dioscorea oppositifolia Source : Rhizome(s) Extraction ratio : 1.2:1 Dry plant equivalent : 56.25 mg | 48.5 mg | Not calculated |
| Magnetitum Source : Stone Extraction ratio : 1.2:1 Dry plant equivalent : 14.06 mg | 11.3 mg | Not calculated |
| Paeonia suffruticosa Source : Écorce de racine Extraction ratio : 5:1 Dry plant equivalent : 41.25 mg | 8.3 mg | Not calculated |
| Cornus officinalis Source : Fruit(s) Extraction ratio : 2.8:1 Dry plant equivalent : 56.25 mg | 20.1 mg | Not calculated |
| Alisma plantago-aquatica Source : Rhizome(s) Extraction ratio : 5:1 Dry plant equivalent : 41.25 mg | 8.25 mg | Not calculated |
| Bupleurum chinense Source : Racine Extraction ratio : 7:1 Dry plant equivalent : 14.06 mg | 2 mg | Not calculated |
Non-medicinal ingredients
Amidon
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 8 Pilule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
This Traditional Chinese Medicine helps replenish the kidney and subdue hyperactivity of the liver. It is used for deficiency of yin of the liver and the kidney marked by tinnitus, impairment of hearing, dizziness and blurred vision.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80008736
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2009. Photograph the packaging to check whether it has changed. Photograph the packaging